Market Place
Sourcing Support
All News #Library
Rare Diseases
Eton Pharmaceuticals Announces CFO Succession Plan
16 Apr 2026 //
GLOBENEWSWIRE
FDA approves Eton`s liquid therapy for rare water-balance
25 Feb 2026 //
REUTERS
Eton Pharma Licenses Rare Disease Product Candidate
02 Feb 2026 //
GLOBENEWSWIRE
Eton Pharma To Attend 16th Craig-Hallum Alpha Select Conference
12 Nov 2025 //
GLOBENEWSWIRE
Eton Pharma`s New Drug ET-600 Receives FDA Acceptance
08 Jul 2025 //
GLOBENEWSWIRE
Eton Pharmaceuticals Reports Positive Study Results for ET-600
14 Mar 2025 //
GLOBENEWSWIRE
Eton Advances Commitment to Rare Disease with Acquisition of Galzin
04 Jan 2025 //
GLOBENEWSWIRE
Eton Pharmaceuticals Acquires U.S. Rights to Amglidia Suspension
25 Nov 2024 //
GLOBENEWSWIRE
Eton Pharmaceuticals, Inc to Acquire Increlex® from Ipsen
03 Oct 2024 //
GLOBENEWSWIRE
Eton Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
04 Oct 2023 //
GLOBENEWSWIRE
Eton Pharma Announces Acquisition of Rare Disease Product Candidate ET-600
15 Mar 2023 //
GLOBENEWSWIRE
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product
13 Sep 2022 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.